Chinook Therapeutics Inc (NASDAQ:KDNY)
| 19.65 Delayed Data As of Sep 30 |  +0.17 / +0.87%Today’s Change | 10.48 Today|||52-Week Range 23.86 | +20.48% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 73.0M | 50.7M | 17.2M | 15.1M | |
| Depreciation And Amortization | 723.0K | 2.6M | 4.0M | 5.0M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 85.8M | 111.7M | 107.5M | 95.3M | ||
| Research And Development | 58.6M | 83.7M | 81.2M | 67.7M | ||
| Total Operating Expenses | 86.5M | 114.3M | 111.5M | 100.2M | ||
| Non-Operating Expenses | Operating Income | -13.6M | -63.6M | -94.3M | -85.1M | |
| Extraordinary Charge | -26.1M | -8.3M | -12.2M | -16.2M | ||
| Other Expenses | -161.0K | -40.0K | -218.0K | -64.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -39.3M | -69.7M | -103.2M | -96.1M | |
| Income Taxes | -99.0K | -21.5M | -11.4M | -783.0K | ||
| Net Income | -39.2M | -91.1M | -91.9M | -95.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 44.7M | 65.2M | 72.9M | 78.8M | |
| Shares To Calculate EPS Diluted | 44.7M | 65.2M | 72.9M | 78.8M | ||
| Earnings Per Share | EPS | -$0.88 | -$1.40 | -$1.26 | -$1.21 | |
| EPS Diluted | -$0.88 | -$1.40 | -$1.26 | -$1.21 | ||
